Grahek, Rok
Rok Grahek
VIAF ID: 92154440168935341804 (Personal)
Permalink: http://viaf.org/viaf/92154440168935341804
Preferred Forms
- 100 1 _ ‡a Grahek, Rok
- 100 0 _ ‡a Rok Grahek
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
6-halo benzo[a]pyrene 7,8-dihydrodiol analogs : synthesis, chiral separation, and CD properties | |
Active pharmaceutical ingredient adsorbed on solid support : EP2416775 (A1) - 2012-02-15 | |
Afatinib-containing formulation : United States patent US10,702,477 B2, 2020-07-07 | |
The antibiotic gentamicin C complex:hplc isolation and fab mass spectrometry study | |
Characterisation of polymer excipients by size exclusion chromatography and light scattering based detection | |
Chemical Stability of Pravastatin in Acidic media | |
Chromatographic purification of some HMG-CoA reductase inhibitors | |
Čist vankomicin hidroklorid. | |
Coated particles and pharmaceutical dosage forms : European patent specification EP 1594474 B1, 2017-03-22 | |
Combination of analytical and semipreparative HPLC for determiantion of Sisomicin in Gentamicin | |
Conversion of clindamycin into novel lincomycin into novel lincomycin analogues-4,7-anhydrolincomycin and lincomycin | |
Določanje ostankov topil v zdravilih | |
Enantioselective separation of ofloxacin by capillary zone electrophoresis | |
Fast analysis of pravastatin in production media | |
Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination | |
Fragmentation study of atorvastatin and some analogues using electrospray ionization mass spectrometry | |
Identification of an impurity in pravastatin by application of collision-activated decomposition mass spectra | |
Identification of three impurities in amlodipine | |
Identifikacija nečistoč v gentamicinu s tandemsko masno spektrometrijo : doktorska disertacija | |
Ionizacija nekaterih organokovinskih fluoridov pri atmosferskem tlaku in njihovi masni spektri | |
Izolacija in določitev strukture nečistoč v linkomicinu | |
Izolacija in identifikacija metabolitov atorvastatina | |
Izolacija komponent gentamicin-c kompeksa s semipreparativno hplc metodo | |
Macrogols effect on stability performance of drug product | |
Masna spektrometrija v farmacevtski analizi | |
Mass spectometry as the basis of Lek's high quality | |
N-{trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl}-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue | |
NDMA formation due to active ingredient degradation and nitrite traces in drug product | |
Nečistoče - določitev profila nečistoč API | |
Nečistoče in razkrojni produkti kalijevega klavulanata | |
New procedure for obtaining chromatographically pure antibiotics and their synthesis intermediates. | |
Nitrocellulose blister material as a source of N-nitrosamine contamination of pharmaceutical drug products | |
Nov postopek za pridobivanje kromatografsko čistih antibiotikov in njihovih sinteznih intermediatov : patent : SI 9800141 (A), 1999-12-31 | |
Obloženi delci in farmacevtske oblike | |
Oxidation stability of abiraterone acetate : WO2014009437 (A1) - 2014-01-16 : international publication date 16 January 2014 | |
Oxidative degradation products of atorvastatin calcium : patentna prijava : US 2010/056605 (A1), 2010-09-02 | |
Peptide sequencing by mass spectrometry | |
Pharmaceutical compositions ; patentna prijava : WO 2005/084669 (A1), 2005-09-15 | |
Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze. | |
Preparation of amlodipine enantiomers by chromatographic separation | |
Preparative HPLC isolation of clindamycin-2-phosphate impurities | |
Preparative hplc purification of pentapeptide analogue of thymopentin | |
Proč z nečistočami (z industrijsko uporabo hplc - high performance liquid chromatography) | |
Process for obtaining HMG-CoA reductase inhibitors of high purity : United States patent US 6695969 B1, 2004-02-24 | |
A process for the purification of crude vancomycin : patent : EP 1824874 (B1), 2009-04-01 | |
Process of purification of teicoplanin : patentna prijava : EP 2592090 (A1), 2013-05-15 | |
Pure vancomycin hydrocloride. | |
Raziskava profila in izvora nečistoč v amlodipinu benzensulfonatu | |
Raziskave diastereoizomernih dipeptidov z metodo MS/MS = MS/MS determination of diastereoisomeric dipeptides | |
Različne obdelave in predstavitve večparametričnih podatkov | |
Sinteza in karakterizacija piridinijevega tetrakloro in tetrabromodipiridinmolibdata (III) : diplomsko delo | |
Solid pharmaceutical compositions of androgen receptor antagonists : WO2015118015 (A1) - 2015-08-13 | |
Solute-CSP interactions in the enantiomeric resolution of benzo[a]pyrene dihydrodiol and 6-halo analogues on cellulose-based stationary phases | |
Sources of impurities - investigation of 4-2(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[(2-phthalimi doethoxy)methyl]-1,4-dihydropyridine traces formation during the synthesis of amlodipine besylate = Izvori nečistoč - raziskave tvorbe sledov 4-(2-klorofenil)-3-etoksikarbonil-5-metoksikarbonil-6-metil-2-[(2-ftalimido)-me til]-1,4-dihidropiridina med sintezo malodipin bezilata | |
Spremljanje izomerizacije enalaprila s pomočjo tekočinske kromatografije | |
Stability and degradation pathways of N-nitroso-hydrochlorothiazide and the corresponding aryl diazonium ion | |
Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino. | |
Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze : patent SI 21400 A, 2004-08-31 | |
Stable pharmaceutical dosage form comprising HMG-CoA reductase inhibitor. | |
Stablized pharmaceutical preparation comprising an amorphous active substance : patent : EP 1608362 (B1), 2007-02-21 | |
Structure determination of lincomycin impurities = Identifikacija strukture nečistot linkomicina | |
Structure determination of tamsulosin impurities by tandem mass spectrometry | |
Study of different sources of nitrosamine traces in pharmaceuticals by highly sensitive hyphenated mass spectrometry techniques oral presentations | |
Study of preparative hplc separation of linkomycin b from linkomycin. Experimental and theoretical results | |
Synthesis of clavam-2-carboxylic acid and its identification in potassium clavulanate samples | |
The synthesis, purification and structure confirmation of some thymopentin analalogues | |
Temperature effect on rotamers behaviour of some ac-inhibitors | |
Uporaba različnih tehnik MS v farmacevtski industriji = Different MS techniques in pharmaceutical industry | |
Use of preparative hplc in garamine synthesis | |
Vpliv strukturnih elementov v molekuli na inhibicijsko delovanje tricikličnih inhibitorjev ß-laktamaze |